Cardio Diagnostics Holdings Inc. Common stock (CDIO)

Price$1.96

Growth ScoreC

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-39.87%

Price vs S&P 500 (4W)7.11%

VGM Score43.13

Market Capitalization$5.80M

All Metrics

Book Value / Share (Quarterly)$3.01

P/TBV (Annual)0.81x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-2.14

Price vs S&P 500 (YTD)-35.83%

Net Profit Margin (TTM)-40116.22%

EPS (TTM)$-3.38

10-Day Avg Trading Volume0.08M

EPS Excl Extra (TTM)$-3.38

EPS (Annual)$-3.71

ROI (Annual)-89.71%

Cash / Share (Quarterly)$2.39

Revenue Growth QoQ (YoY)185.11%

ROA (Last FY)-83.67%

Revenue Growth TTM (YoY)-16.68%

EBITD / Share (TTM)$-3.24

ROE (5Y Avg)-126.08%

Operating Margin (TTM)-40038.24%

Cash Flow / Share (Annual)$-3.37

P/B Ratio0.65x

P/B Ratio (Quarterly)0.65x

Net Income / Employee (Annual)$-433,200

EV / Revenue (TTM)-66.82x

Net Interest Coverage (TTM)-460.19x

ROA (TTM)-72.87%

EPS Incl Extra (Annual)$-3.71

Current Ratio (Annual)9.79x

Quick Ratio (Quarterly)14.41x

3-Month Avg Trading Volume2.54M

52-Week Price Return-56.64%

Revenue / Employee (TTM)$1,100

Tangible BV / Share (Quarterly)$2.69

P/S Ratio (Annual)391.14x

Asset Turnover (Annual)0.00x

52-Week High$7.91

EPS Excl Extra (Annual)$-3.71

CapEx CAGR (5Y)69.47%

26-Week Price Return-31.94%

Quick Ratio (Annual)8.46x

13-Week Price Return-63.50%

Total Debt / Equity (Annual)0.04x

Current Ratio (Quarterly)15.76x

Enterprise Value$-1.11M

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$1,000

Pretax Margin (Annual)-43817.73%

Cash / Share (Annual)$2.80

3-Month Return Std Dev117.68%

Net Income / Employee (TTM)$-443,400

ROE (Last FY)-93.19%

Net Interest Coverage (Annual)-514.60x

EPS Basic Excl Extra (Annual)$-3.71

Receivables Turnover (TTM)2.40x

Total Debt / Equity (Quarterly)0.02x

EPS Incl Extra (TTM)$-3.38

Receivables Turnover (Annual)1.11x

ROI (TTM)-77.64%

P/S Ratio (TTM)349.85x

Revenue / Share (Annual)$0.01

Tangible BV / Share (Annual)$3.34

Price vs S&P 500 (52W)-81.00%

Year-to-Date Return-27.68%

5-Day Price Return-7.98%

EPS Normalized (Annual)$-3.71

ROA (5Y Avg)-96.26%

Net Profit Margin (Annual)-43817.73%

Month-to-Date Return3.70%

EBITD / Share (Annual)$-3.66

Operating Margin (Annual)-43722.66%

ROI (5Y Avg)-114.91%

EPS Basic Excl Extra (TTM)$-3.38

P/TBV (Quarterly)0.72x

P/B Ratio (Annual)0.71x

Pretax Margin (TTM)-40116.22%

Book Value / Share (Annual)$3.82

Price vs S&P 500 (13W)-71.76%

Beta2.27x

Revenue / Share (TTM)$0.01

ROE (TTM)-78.82%

52-Week Low$0.97

gGradeC

mGradeD

vgmGradeC

Show chart for

Analyst Recommendations

Jun 2025

Jul 2025

Aug 2025

Oct 2025

4.14

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	Price
CDIOCardio Diagnostics Holdings Inc. Common stock	—	C	D	$1.96
IDXXIdexx Laboratories Inc	D	B	C	$562.16
LNTHLantheus Holdings, Inc	C	B	B	$100.98
NNNNAnbio Biotechnology Class A Ordinary Shares	F	B	B	$22.99
CLDXCelldex Therapeutics, Inc	F	F	C	$28.62
NEOGNeogen Corp	C	C	B	$8.90
NTLAIntellia Therapeutics, Inc	D	C	B	$13.54
QDELQuidelOrtho Corporation Common Stock	C	C	D	$14.33
ACHVAchieve Life Sciences, Inc.	F	F	B	$5.13
MYGNMyriad Genetics Inc	C	C	C	$4.57
TKNOAlpha Teknova, Inc. Common Stock	C	C	B	$4.56

About

Cardio Diagnostics Holdings Inc develops AI-powered epigenetics-based clinical tests for coronary heart disease risk assessment, detection, and management. The company's diagnostic platform combines epigenetic and genetic biomarkers to provide personalized clinical insights for healthcare providers. Its three main solutions—Epi+Gen CHD, PrecisionCHD, and Actionable Clinical Intelligence—enable better identification and management of patients at risk for coronary events.